Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Amygdala atrophies in specific subnuclei in preclinical Alzheimer's disease

Alzheimer s & Dementia(2024)10.1002/alz.14235Source: DataRank Database

Amygdala atrophies in specific subnuclei in preclinical Alzheimer's disease is a research paper published in Alzheimer s & Dementia (2024). On theSindex it has a DataRank of 0. It has been cited 23 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access23 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (57 grants)Impact (FWCI 6.63)OA: hybridTopics (60)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Thomas Gérard ORCID,Lara Huyghe ORCID,Lise Colmant ORCID,Lisa Quenon ORCID,Vincent Malotaux ORCID

Live enrichment

PubMed:39254209 PMC:PMC11485073 OpenAlex:https://openalex.org/W4402414489

Belgian Fund for Scientific Research (FNRS)

Grant: CCL40010417

Belgian Fund for Scientific Research (FNRS)

Grant: FRIA40014635

FRFS-WELBIO

Grant: 40010035

NIA NIH HHS

Grant: U01 AG024904

Alzheimer's Disease Neuroimaging Initiative (ADNI)

Grant: W81XWH-12-2-0012

National Institutes of Health

Grant: 1U01AG024904-01

Alzheimers Disease Neuroimaging Initiative

Canadian Institutes of Health Research

Grant: unidentified

unidentified

Alzheimer's Therapeutic Research Institute at the University of Southern California

NIBIB NIH HHS

National Institute on Aging

NeuroRx Research

Roche

U.S. Department of Defense

Belgian Alzheimer Research Foundation

BioClinica, Inc

CIHR

Eisai Inc.

Pfizer Inc.

Araclon Biotech

Canadian Institutes of Health Research

Lumosity

Merck & Co., Inc.

Neurotrack Technologies

Pfizer

Takeda Pharmaceutical Company

GE Healthcare

Genentech, Inc.

IXICO Ltd

Laboratory for Neuro Imaging at the University of Southern California

National Institutes of Health

Northern California Institute for Research and Education

Piramal Imaging

Transition Therapeutics

Alzheimer's Drug Discovery Foundation

Alzheimer's Association

Bristol-Myers Squibb Company

Department of Defense

Elan Pharmaceuticals, Inc.

Eli Lilly and Company

Servier

Alzheimer's Association

Alzheimer's Drug Discovery Foundation

Biogen

Cogstate

NIH HHS

National Institute of Biomedical Imaging and Bioengineering

AbbVie

Bristol-Myers Squibb

CereSpir, Inc

Janssen Alzheimer Immunotherapy Research & Development, LLC.

Novartis Pharmaceuticals Corporation

EuroImmun

F. Hoffmann-La Roche Ltd

Genentech

Johnson & Johnson Pharmaceutical Research & Development LLC

Merck

Meso Scale Diagnostics, LLC.

FWCI

6.63

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

hybridLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.14235

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.14235

publisherhttps://alz-journals.onlinelibrary.wiley.com/doi/pdf/10.1002/alz.14235

journalhttps://doi.org/10.1002/alz.14235

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39254209

Fields of Study

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsMemory and Neural Mechanisms03 medical and health sciences0302 clinical medicine

MeSH Terms

AgedAged, 80 and overAlzheimer DiseaseAmygdalaAtrophyFemaleHippocampusHumansMagnetic Resonance ImagingMaleTemporal LobeBiomarkersAmyloid beta-Peptidestau ProteinsPositron-Emission TomographyNeuroimaging

Keywords

AmygdalaNeuroscienceAtrophyTemporal lobeHippocampal formationNeuroimagingTauopathyPsychologyAlzheimer's diseaseDementiaEntorhinal cortexBasal gangliaHippocampusMagnetic resonance imagingMedicinePathologyDiseaseNeurodegenerationCentral nervous systemBiomarkerStructural Magnetic Resonance ImagingPreclinical AdAmygdala SubnucleiFlortaucipirAv1451Mk6240FlorquinitauTau‐positron Emission TomographyMaletau ProteinsAlzheimer DiseaseHumansAgedAged, 80 and overAmyloid beta-PeptidesPositron-Emission TomographyFemaleBiomarkersResearch Article

Sustainable Development Goals

SDG 0: Good health and well-being